dragen ultra-rapid next generation sequencing data analysis platform (Illumina Inc)
90
Structured Review
Illumina Inc
dragen ultra-rapid next generation sequencing data analysis platform
Dragen Ultra Rapid Next Generation Sequencing Data Analysis Platform, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/generation+sequencing+data+analysis/dragen/pmc11300456-455-0-6
Average 90 stars, based on 1 article reviews
Dragen Ultra Rapid Next Generation Sequencing Data Analysis Platform, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/generation+sequencing+data+analysis/dragen/pmc11300456-455-0-6
Average 90 stars, based on 1 article reviews
dragen ultra-rapid next generation sequencing data analysis platform - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Identification of technically challenging variants - whole genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases. Article Snippet: .. The HKGP employs Illumina PCR-free short read WGS coupled with multiple bioinformatics tools, including Variant Assay:Article Title: Identification of technically challenging variants - whole genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases. Article Snippet: .. The HKGP employs Illumina PCR-free short read WGS coupled with multiple bioinformatics tools, including Article Title: CT-based radiogenomic analysis to predict high-risk colon cancer (ATTRACT): a multicentric trial. Article Snippet: Objective Clinical staging on CT has several biases, and a radiogenomics approach could be proposed.. The study aimed to test the performance of a radiogenomics approach in identifying high-risk colon cancer.. Material and methods ATTRACT is a multicentric trial, registered in ClinicalTrials.gov (NCT06108310). Article Title: Identification of technically challenging variants: Whole-genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases Article Snippet: .. To overcome the challenge in high-homology sequences, an integrated approach considering the estimated copy numbers of both genes and pseudogenes, haplotyping information, and the possibility of recombination events was used to increase the accuracy of variant calling by Illumina’s Article Title: Identification of technically challenging variants - whole genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases. Article Snippet: .. To overcome the challenge in high homology sequence, an integrated approach considering estimated copy number of both genes and pseudogenes, haplotyping Jo ur al Pr e-p roo f 26 information and the possibility of recombination events were used to increase the accuracy of variant calling by Illumina’s Software:Article Title: δ-Containing GABA A receptors on parvalbumin interneurons modulate neuronal excitability and network dynamics in the mouse medial prefrontal cortex. Article Snippet: In medial prefrontal cortex (mPFC), fast-spiking parvalbumin (PV) interneurons regulate excitability and microcircuit oscillatory activity important for cognition.. Although PV interneurons inhibit pyramidal neurons, they themselves express d subunits of GABAA receptors important for slow inhibition.. However, the specific contribution of d-containing GABAA receptors to the function of PV interneurons in mPFC is unclear. Article Title: Pangenome-aware DeepVariant Article Snippet: .. Noticeably, Sequencing:Article Title: Identification of technically challenging variants - whole genome sequencing improves diagnostic yield in patients with high clinical suspicion of rare diseases. Article Snippet: .. To overcome the challenge in high homology sequence, an integrated approach considering estimated copy number of both genes and pseudogenes, haplotyping Jo ur al Pr e-p roo f 26 information and the possibility of recombination events were used to increase the accuracy of variant calling by Illumina’s |